DK0508993T3 - Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derfor - Google Patents
Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derforInfo
- Publication number
- DK0508993T3 DK0508993T3 DK91900689.0T DK91900689T DK0508993T3 DK 0508993 T3 DK0508993 T3 DK 0508993T3 DK 91900689 T DK91900689 T DK 91900689T DK 0508993 T3 DK0508993 T3 DK 0508993T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- treatment
- pharmaceutical compositions
- compositions containing
- antibody complexes
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 208000023275 Autoimmune disease Diseases 0.000 abstract 2
- 206010052779 Transplant rejections Diseases 0.000 abstract 2
- 230000001900 immune effect Effects 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000036647 reaction Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6056—Antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Rehabilitation Therapy (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46051490A | 1990-01-03 | 1990-01-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0508993T3 true DK0508993T3 (da) | 1994-05-09 |
Family
ID=23829022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91900689.0T DK0508993T3 (da) | 1990-01-03 | 1990-12-31 | Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derfor |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7122380B1 (de) |
| EP (1) | EP0508993B1 (de) |
| JP (1) | JPH03227942A (de) |
| AT (1) | ATE103495T1 (de) |
| AU (1) | AU644400B2 (de) |
| CA (1) | CA2015515C (de) |
| DE (1) | DE69007799T2 (de) |
| DK (1) | DK0508993T3 (de) |
| ES (1) | ES2054484T3 (de) |
| HU (1) | HUT62486A (de) |
| IE (1) | IE65399B1 (de) |
| NO (1) | NO922621L (de) |
| PL (1) | PL288597A1 (de) |
| PT (1) | PT96409A (de) |
| WO (1) | WO1991009619A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2095956T3 (es) * | 1990-09-28 | 1997-03-01 | British Tech Group | Conjugados antigeno-anticuerpo. |
| US5620686A (en) * | 1990-09-28 | 1997-04-15 | British Technology Group Limited | Antigen-antibody conjugates |
| NZ263102A (en) * | 1993-03-19 | 1997-05-26 | Immunex Corp | Pharmaceutical compositions comprising a ligand protein such as interleukin-4 and a soluble receptor protein that binds thereto |
| FR2728264B1 (fr) * | 1994-12-16 | 1997-01-31 | Rhone Poulenc Rorer Sa | Purification d'adn par formation de triple helice avec un oligonucleotide immobilise |
| AUPO269996A0 (en) * | 1996-10-01 | 1996-10-24 | Walter And Eliza Hall Institute Of Medical Research, The | A method of prophylaxis and treatment |
| AU1267501A (en) * | 1999-09-07 | 2001-04-10 | Bioserv Ag | Novel autogenous vaccines used to obtain an immune tolerance |
| AU2003232872A1 (en) | 2002-05-27 | 2003-12-12 | Ostergotlands Lans Landsting | Method for determining immune system affecting compounds |
| CN1863555A (zh) | 2003-08-15 | 2006-11-15 | 卡尔加里大学理事会 | 操作哺乳动物中抗原特异性抗体的水平的组合物和方法 |
| AU2011218660B2 (en) * | 2003-08-15 | 2011-12-15 | The Governors Of The University Of Calgary | Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal |
| SE0402536D0 (sv) | 2004-10-20 | 2004-10-20 | Therim Diagnostica Ab | Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
| EP1875246B1 (de) | 2005-04-15 | 2016-10-05 | CanImGuide Therapeutics AB | Diagnoseverfahren zum nachweis von krebs durch messen der menge eines cytokinähnlichen il-6 |
| GB2440528A (en) * | 2006-07-27 | 2008-02-06 | Ist Superiore Sanita | Antigen-antibody complexes |
| ES2608803T3 (es) | 2007-05-08 | 2017-04-17 | Canimguide Therapeutics Ab | Estructuras inmunorreguladoras procedentes de proteínas naturales |
| WO2017218677A2 (en) * | 2016-06-14 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis |
| GB201802338D0 (en) | 2018-02-13 | 2018-03-28 | Univ Oslo | Antigen binding proteins |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4140679A (en) | 1976-10-12 | 1979-02-20 | Research Corporation | Antigen-protein complex for blocking allergic reactions |
| US4234569A (en) | 1978-10-04 | 1980-11-18 | The Johns Hopkins University | Production of aldehyde-treated allergen-containing substances |
| DE2846412A1 (de) | 1978-10-25 | 1980-05-08 | Behringwerke Ag | Mittel zur behandlung allergischer reaktionen |
| US4521405A (en) | 1982-05-17 | 1985-06-04 | John McMichael | Methods and materials for treatment of disease states involving immunological factors |
| US4545986A (en) | 1982-06-22 | 1985-10-08 | Research Corporation | Timothy grass antigen specific anti-idiotypic antibodies |
| US4564600A (en) | 1982-10-26 | 1986-01-14 | Majid Ali | Allergens and antibodies from allergen extracts and pooled serum |
| US4702907A (en) | 1983-08-09 | 1987-10-27 | Cornell Research Foundation, Inc. | Process for inducing selective immunosuppression of antibodies |
| US4681760A (en) | 1985-04-17 | 1987-07-21 | The Board Of Trustees Of The Leland Stanford Junior University | Method of conferring immunotolerance to a specific antigen |
| CA1282069C (en) | 1985-09-12 | 1991-03-26 | Damon L. Meyer | Antibody complexes of hapten-modified diagnostic or therapeutic agents |
| US4714759A (en) | 1985-12-02 | 1987-12-22 | Whitaker Jr Robert B | Immunotoxin therapy of allergy |
| GB8608068D0 (en) | 1986-04-02 | 1986-05-08 | Cobbold S P | Monoclonal antibodies |
| GB8610983D0 (en) | 1986-05-06 | 1986-06-11 | Connaught Lab | Enhancement of antigen immunogenicity |
| DE68925899T2 (de) * | 1988-04-04 | 1996-10-02 | Byron E Anderson | Bindung von immunkomplexen durch modifizierte formen von c-reaktiven proteinen |
-
1990
- 1990-04-26 CA CA002015515A patent/CA2015515C/en not_active Expired - Fee Related
- 1990-05-23 JP JP2133680A patent/JPH03227942A/ja active Pending
- 1990-12-21 IE IE469390A patent/IE65399B1/en not_active IP Right Cessation
- 1990-12-31 DE DE69007799T patent/DE69007799T2/de not_active Expired - Fee Related
- 1990-12-31 WO PCT/BE1990/000074 patent/WO1991009619A1/en not_active Ceased
- 1990-12-31 ES ES91900689T patent/ES2054484T3/es not_active Expired - Lifetime
- 1990-12-31 AU AU69626/91A patent/AU644400B2/en not_active Ceased
- 1990-12-31 DK DK91900689.0T patent/DK0508993T3/da active
- 1990-12-31 AT AT91900689T patent/ATE103495T1/de not_active IP Right Cessation
- 1990-12-31 HU HU9202214A patent/HUT62486A/hu unknown
- 1990-12-31 EP EP91900689A patent/EP0508993B1/de not_active Expired - Lifetime
-
1991
- 1991-01-02 PT PT96409A patent/PT96409A/pt not_active Application Discontinuation
- 1991-01-03 PL PL28859791A patent/PL288597A1/xx unknown
-
1992
- 1992-07-02 NO NO92922621A patent/NO922621L/no unknown
-
1994
- 1994-05-13 US US08/242,076 patent/US7122380B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69007799T2 (de) | 1994-10-20 |
| AU644400B2 (en) | 1993-12-09 |
| EP0508993A1 (de) | 1992-10-21 |
| NO922621L (no) | 1992-09-02 |
| ATE103495T1 (de) | 1994-04-15 |
| PL288597A1 (en) | 1991-08-12 |
| WO1991009619A1 (en) | 1991-07-11 |
| PT96409A (pt) | 1991-10-15 |
| HU9202214D0 (en) | 1992-10-28 |
| NO922621D0 (no) | 1992-07-02 |
| CA2015515C (en) | 1999-12-07 |
| AU6962691A (en) | 1991-07-24 |
| IE65399B1 (en) | 1995-10-18 |
| IE904693A1 (en) | 1991-07-17 |
| CA2015515A1 (en) | 1991-07-03 |
| JPH03227942A (ja) | 1991-10-08 |
| DE69007799D1 (de) | 1994-05-05 |
| ES2054484T3 (es) | 1994-08-01 |
| US7122380B1 (en) | 2006-10-17 |
| HUT62486A (en) | 1993-05-28 |
| EP0508993B1 (de) | 1994-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA29494C2 (uk) | Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція | |
| DK0508993T3 (da) | Farmaceutiske præparater indeholdende antigen-antistofkomplekser og anvendelse derfor | |
| EP0735893A4 (de) | Veränderung der immunantwort durch verwendung von pan dr-bindeproteinen | |
| MY111682A (en) | Altered antibodies and their preparations. | |
| FI960102A0 (fi) | Uusi farmaseuttinen seos | |
| ATE155818T1 (de) | Nicht glycosylierter anti-cd3-igg-antikörper | |
| DE69033487D1 (de) | Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol | |
| IL108501A0 (en) | Novel antibodies and pharmaceutical compositions containing them | |
| FR2516794B1 (fr) | Nouveaux medicaments anticancereux pour le traitement des leucemies t constitues de la chaine a de la ricine et d'un anticorps monoclonal specifique | |
| GB2301366A (en) | Antibodies against E-selectin | |
| DE69432309D1 (de) | Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen | |
| PT1331944E (pt) | Utilização de anticorpos monoclonais específicos para cd28 para a estimulação de células sanguíneas que não comportam qualquer cd28 | |
| DK0969873T3 (da) | Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf | |
| FI972703A0 (fi) | Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia | |
| EP0350690A3 (de) | Neutralisation der in vitro- und in vivo-toxischen Eigenschaften von TNF-alfa durch monoklonale Antikörper und die davon abgeleiteten Fragmente | |
| CA2055615A1 (en) | Monoclonal antibodies for inducing tolerance | |
| SG48816A1 (en) | Gonococcal anti-idiotypic antibodies and methods and compositions using them | |
| ES2196150T3 (es) | Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion. | |
| AU6819600A (en) | Use of cd28 specific monoclonal antibodies for producing a pharmaceutical composition for treating virus infections | |
| BG103416A (en) | Soluble lymphotoxin-beta receptors, antilymphotosoluble lymphotoxin- receptors, antilymphotoxin receptor antibodies and antilymphotoxin ligand antixin receptor antibodies and antilymphotoxin ligandbodies as therapeutical forms for the treatment of antibodies as therapeutical forms for the treatment of immunological diseases immunological diseases | |
| ATE205480T1 (de) | 2,5-dioxo-2,5-dihydro-1h-benz(b)azepine als nmda rezeptor antagonisten | |
| EP0817650A4 (de) | Synthetische peptide und diese enthaltende arzneimittel zur behandlung des systemischen lupus erythematodes | |
| CA2157500A1 (en) | Lo-cd2a antibody and uses thereof for inhibiting t-cell activation and proliferation | |
| Strong et al. | Antigenic characterization of a T-CLL with heteroantisera and monoclonal antibodies: evidence for the T cell lineage of an Ia-positive, Fc-IgG--positive, suppressor-cell subpopulation. | |
| DE59207362D1 (de) | Monoklonale Antikörper gegen den Plasmin-Antiplasmin Komplex, Verfahren zu ihrer Herstellung sowie ihre Verwendung |